Aesthetic Medical International Holdings Group Limited Announces Pricing of Initial Public Offering

VCBeat (WeChat ID: vcbeat) has learned that on October 25, 2019, Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) (hereinafter referred to as “Aesthetic Medical International” or the “Company”), a leading provider of aesthetic medical services in China, announced today its initial public offering of 2,500,000 American Depositary Shares (ADSs), at an offering price of $12.00 per ADS, with each ADS representing three ordinary shares of the Company.

In the event that the underwriters do not exercise their over-allotment option, the total proceeds from this public offering are expected to be approximately $30.0 million. The Company’s American Depositary Shares (ADSs) are scheduled to begin trading on the Nasdaq Global Market under the ticker symbol “AIH” on October 25, 2019, Eastern Time. Subject to customary closing conditions, the offering is expected to close on October 29, 2019.

Pursuant to the over-allotment option granted by the Company to the underwriters, the underwriters may purchase up to an additional 375,000 ADSs at the initial public offering price less the underwriting discounts and commissions within 30 days from the date of the final prospectus. If the underwriters do not exercise their over-allotment option, the total gross proceeds from this public offering are expected to be approximately US$30.0 million. If the underwriters fully exercise their over-allotment option, the total gross proceeds from this public offering will be approximately US$34.5 million.

Cantor Fitzgerald & Co., Haitong International Securities Company Limited, and Prime Capital served as joint bookrunners for this offering. Maxim Group LLC, Tiger Brokers, and Huasheng Capital Securities Company Limited served as co-managers for this offering.

Medical Beauty International, also known as Pengai Medical Aesthetics in China, is a leading provider of aesthetic medical services in the country. Its treatment centers are located in 15 cities across mainland China, as well as in Hong Kong and Singapore. With over 20 years of clinical experience, Medical Beauty International offers one-stop aesthetic services, including surgical cosmetic treatments, non-surgical cosmetic treatments, general healthcare, and other beauty services. According to third-party industry consultants, Medical Beauty International was the third-largest private aesthetic medical service provider in China by revenue in 2018.